NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data

Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access SEATTLE-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a collaboration for the development of new analysis tools for data generated on NanoString’s nCounter® [...]

Genetron Health Announces Strategic Collaboration with DARUI on GENETRON S5 Platform

BEIJING--(BUSINESS WIRE)-- Genetron Holdings Limited (“Genetron Health”), a China-based precision oncology company that covers full-cycle cancer care, announced that it has joined forces with DARUI. The partnership will support DARUI at developing pathogenic microorganism detection products and applying for registration of reagent kits using the NGS sequencer GENETRON S5 (Registration Number 20193220820). Featuring diverse application [...]

Launch of the Lexogen Web Solution, Powered by BlueBee, to Streamline the Path to Discovery for Lexogen Customers

Lexogen and BlueBee have launched a new, web-based data analysis portal to provide a more user‑friendly experience for Lexogen kit users analyzing RNA sequencing data. With the Lexogen web solution configuration on the BlueBee Genomics Platform, data upload is easier than ever— files can be uploaded with a simple “drag and drop” function (Figure 1) [...]

Tosoh Bioscience Introduces TSKgel UP-SW Aggregate UHPLC/HPLC Columns

Providing superior separation for high order aggregates and macromolecules   King of Prussia, PA - Tosoh Bioscience LLC, a provider of chromatographic solutions for the separation of biomolecules, announced today the introduction of TSKgel UP-SW Aggregate size exclusion chromatography (SEC) columns. These columns are the latest addition to the TSKgel UP-SW series and are now available for sale [...]

Cambridge Isotope Laboratories Partners With Alsachim in the Fight Against COVID-19

TEWKSBURY, Mass. -- Through a commercial partnership with Alsachim, Cambridge Isotope Labs (CIL) is proud to now offer an assortment of unlabeled and stable isotope-labeled antiviral drug standards and their metabolites to assist in COVID-19 research and therapy development. "We are thrilled to join forces with CIL in order to answer U.S. customers' needs and [...]

University of Paris Researchers Utilize Fluidigm Mass Cytometry and Maxpar Direct Immune Profiling Assay to Identify Distinct Phenotype among Patients with Severe COVID-19

Study Suggests That Type I IFN Deficiency in the Blood Could Help Define a High-Risk Population SOUTH SAN FRANCISCO, Calif.  -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that researchers at the University of Paris have utilized mass cytometry to identify profound [...]

New Genedata Imagence 2.0 Automates and Catalyzes HCS Image Analysis

Deep learning-based Genedata Imagence sets new benchmarks for automation, simplifying and accelerating HCS for Biopharma R&D Basel, Switzerland  – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Imagence® 2.0, the latest version of its award-winning enterprise software for high-content screening (HCS) image analysis. Leading biopharmaceutical companies are [...]

QPS Continues to Expand UPLC-HRMS Quantitation Capabilities to Support Gene Therapy and Protein Drug Development

NEWARK, Del. -- QPS, a global contract research organization (CRO) that provides discovery, preclinical, and clinical drug development services, is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics. QPS announces an expanded and upgraded fleet of high-resolution mass spectrometers (HRMS), with the addition of three new TripleTOF® HRMS systems for GLP quantitation, two in the Newark, [...]

Rentschler Biopharma licenses Horizon Discovery’s CHOSOURCE platform to complement cell line development offering for difficult-to-express proteins

CHOSOURCE platform to be combined with Rentschler Biopharma’s novel in-house cell line development process to provide speed, stability and high yield Laupheim, Germany; Milford, MA, USA and Cambridge, UK: Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Horizon Discovery, a global leader in the application of gene editing and [...]

10x Genomics Becomes First One Medical Customer to Deploy Cohort-Based COVID-19 Employee Testing

Pioneering Effort for Safe Workplace Reentry SAN FRANCISCO and PLEASANTON, Calif. -- Today, 10x Genomics (Nasdaq: TXG) and One Medical (Nasdaq: ONEM) announced the two organizations are partnering to pioneer a path toward the safe return to work by deploying a comprehensive approach to COVID-19 testing, digital employee symptom screening, and seamless access to remote and in-person care. 10x [...]

Access IBO on Knowledge Center